Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aurinia Pharmaceuticals Inc
AUPH
Healthcare
Biotechnology
Aurinia Pharmaceuticals Inc. is a fully integrated biopharmaceutical company. The Company is focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. It has developed LUPKYNIS (voclosporin), an oral therapy for the treatment of adult patients with active lupus nephritis (LN) and continues to conduct clinical and regulatory activities to support...
the LUPKYNIS development program. The Company is primarily engaged in the development of its pipeline asset AUR200, a differentiated, potential next generation therapy for autoimmune diseases that targets both BAFF (B-cell Activating Factor) and APRIL (A Proliferation-Inducing Ligand). The Company contracted with Otsuka Pharmaceutical Co., Ltd. (Otsuka) as a collaboration partner for the development and commercialization of LUPKYNIS in the Otsuka Territories. It sells LUPKYNIS (voclosporin) primarily to specialty pharmacies and a specialty distributor and directly to its ex-U.S. partner, Otsuka.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:AUPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 02, 2024 4:42pm
Aurinia (NASDAQ:AUPH) Soars on Strong Q1 2024 Results and Pr
https://beyondspx.com/2024/07/31/aurinia-nasdaqauph-soars-on-strong-q1-2024-results-and-promising-outlook/
(46)
•••
Apostata
X
Post by
Apostata
on Dec 15, 2021 4:26pm
Insider Buying
Caught this at the end of today's trading: https://https://newsfilter.io/a/f3900452b2cccee8cead342dda3d2a24m---statement-of-changes-in-beneficial-ownership-of-securities---aurinia
...more
(12)
•••
ZoranSto
X
Post by
ZoranSto
on Dec 09, 2021 12:12pm
More good results
Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) (yahoo.com)
(279)
•••
jboom70
X
Comment by
jboom70
on Dec 04, 2021 5:59pm
RE:RE:RE:WTH ? Happened today ?
New suitor reported again. Short term price changes are just games with the shorts, they have beat this thing hard and won't let it alone. No matter a BO is a set price. This was designed to sell
...more
(8)
•••
TheRainman
X
Comment by
TheRainman
on Nov 22, 2021 4:16pm
RE:RE:WTH ? Happened today ?
I also see there was a shite load of insider sales in November , That is not a good sign.
(50)
•••
TimeScape
X
Comment by
TimeScape
on Nov 22, 2021 3:28pm
RE:WTH ? Happened today ?
Aurinia announced a possible large financing Friday after the close. Obviously, if they are doing a financing, they aren't going to be bought out. The price simply dropped back to what
...more
(8)
•••
TheRainman
X
Post by
TheRainman
on Nov 22, 2021 3:19pm
WTH ? Happened today ?
I don't get it ?
(279)
•••
jboom70
X
Comment by
jboom70
on Nov 10, 2021 5:36pm
RE:Still no offer
I'm patient but hope before the end of the year. Lawyers get payed by the hour, LOL
(12)
•••
ZoranSto
X
Post by
ZoranSto
on Nov 09, 2021 11:32am
Still no offer
I think we should get an offer soon...it has been in play for a few days now...I guess lots of negotiating going on behind the scene...
(279)
•••
jboom70
X
Comment by
jboom70
on Oct 29, 2021 1:40am
RE:RE:RE:RE:RE:RE:Buyout?
Now talk of multiple biders @ +$40
(12)
•••
ZoranSto
X
Comment by
ZoranSto
on Oct 28, 2021 10:21am
RE:RE:RE:RE:RE:Buyout?
Yes that would be great :-)
(50)
•••
TimeScape
X
Comment by
TimeScape
on Oct 26, 2021 6:37pm
RE:RE:RE:RE:Buyout?
RBC upped their target price from $23 to $34 US today. I'd be pretty happy with that price on a takeover.
(279)
•••
jboom70
X
Comment by
jboom70
on Oct 26, 2021 5:10am
RE:RE:RE:Buyout?
Current Sp was heavily manipulated by short sellers. Treatment is est @ $62000 yr but Ive also seen $90000as a price. Gets big fast with decent market penetration, say 30% of 300,000 and that's
...more
(50)
•••
TimeScape
X
Comment by
TimeScape
on Oct 26, 2021 12:51am
RE:RE:Buyout?
The AUPH stock price was $22 before the rumour came out on Friday. A 50% premium would get get it to $33. I doubt an offer would be for much more than that. Maybe $35. AUPH
...more
(279)
•••
jboom70
X
Comment by
jboom70
on Oct 25, 2021 8:42am
RE:Buyout?
No one here? I see $45-$50 buyout but hope for a staight share for share with Bristol as they have pulled back. Thoughts?
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers